EP4366771A1 - A process for the preparation of pure 2-nitro-4-methylsulfonyl benzoic acid - Google Patents
A process for the preparation of pure 2-nitro-4-methylsulfonyl benzoic acidInfo
- Publication number
- EP4366771A1 EP4366771A1 EP22837192.8A EP22837192A EP4366771A1 EP 4366771 A1 EP4366771 A1 EP 4366771A1 EP 22837192 A EP22837192 A EP 22837192A EP 4366771 A1 EP4366771 A1 EP 4366771A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- compound
- formula
- ranges
- acid
- ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 79
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- QNOUABMNRMROSL-UHFFFAOYSA-N 110964-79-9 Chemical compound CS(=O)(=O)C1=CC=C(C(O)=O)C([N+]([O-])=O)=C1 QNOUABMNRMROSL-UHFFFAOYSA-N 0.000 title abstract description 7
- 238000000746 purification Methods 0.000 claims abstract description 26
- 150000001875 compounds Chemical class 0.000 claims description 144
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 35
- 239000002904 solvent Substances 0.000 claims description 31
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- -1 alkali metal sulfite Chemical class 0.000 claims description 12
- GNTDGMZSJNCJKK-UHFFFAOYSA-N divanadium pentaoxide Chemical compound O=[V](=O)O[V](=O)=O GNTDGMZSJNCJKK-UHFFFAOYSA-N 0.000 claims description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 11
- 229910052783 alkali metal Inorganic materials 0.000 claims description 10
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 9
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 8
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 7
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 claims description 7
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 7
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims description 7
- 150000007529 inorganic bases Chemical class 0.000 claims description 7
- 229910017604 nitric acid Inorganic materials 0.000 claims description 7
- 239000001117 sulphuric acid Substances 0.000 claims description 7
- 235000011149 sulphuric acid Nutrition 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 4
- 229940106681 chloroacetic acid Drugs 0.000 claims description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000010265 sodium sulphite Nutrition 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 229960004132 diethyl ether Drugs 0.000 claims description 3
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- UNTBPXHCXVWYOI-UHFFFAOYSA-O azanium;oxido(dioxo)vanadium Chemical compound [NH4+].[O-][V](=O)=O UNTBPXHCXVWYOI-UHFFFAOYSA-O 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000011065 in-situ storage Methods 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 2
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 claims description 2
- 235000019252 potassium sulphite Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 2
- 229910052720 vanadium Inorganic materials 0.000 claims description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical group [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims 1
- 239000012535 impurity Substances 0.000 description 26
- 239000011541 reaction mixture Substances 0.000 description 12
- 239000007787 solid Substances 0.000 description 11
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- ZXVONLUNISGICL-UHFFFAOYSA-N 4,6-dinitro-o-cresol Chemical group CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O ZXVONLUNISGICL-UHFFFAOYSA-N 0.000 description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000005578 Mesotrione Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- KPUREKXXPHOJQT-UHFFFAOYSA-N mesotrione Chemical compound [O-][N+](=O)C1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O KPUREKXXPHOJQT-UHFFFAOYSA-N 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- OXBDLEXAVKAJFD-UHFFFAOYSA-N 1-methyl-4-methylsulfonyl-2-nitrobenzene Chemical compound CC1=CC=C(S(C)(=O)=O)C=C1[N+]([O-])=O OXBDLEXAVKAJFD-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- YYDNBUBMBZRNQQ-UHFFFAOYSA-N 1-methyl-4-methylsulfonylbenzene Chemical compound CC1=CC=C(S(C)(=O)=O)C=C1 YYDNBUBMBZRNQQ-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 229940093475 2-ethoxyethanol Drugs 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- PLAZTCDQAHEYBI-UHFFFAOYSA-N 2-nitrotoluene Chemical compound CC1=CC=CC=C1[N+]([O-])=O PLAZTCDQAHEYBI-UHFFFAOYSA-N 0.000 description 1
- OQFYBGANSUNUAO-UHFFFAOYSA-N 4-methyl-3-nitrobenzenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1[N+]([O-])=O OQFYBGANSUNUAO-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001518005 Callisto Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical compound O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 230000001738 genotoxic effect Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Substances C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
- C07C303/04—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
- C07C303/08—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with halogenosulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C315/00—Preparation of sulfones; Preparation of sulfoxides
- C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
Definitions
- the present invention relates to a novel process for the preparation of a key intermediate, 2-nitro- 4-methylsulfonyl benzoic acid.
- the present invention also relates to a process for the preparation of pure 2-nitro-4-methylsulfonyl benzoic acid.
- Mesotrione is used as a selective herbicide, especially in maize and is sold under brand names such as Callisto and Tenacity. It was first marketed by Syngenta in 2001. Mesotrione is hereinafter referred to as the following compound of Formula II. Formula II.
- the compound of Formula II can be manufactured by reacting the compound of Formula I with phosgene in the presence of an organic solvent to provide the corresponding acid chloride, the acid chloride intermediate can then be reacted with 1,3-cyclohexanedione in the presence of a cyanide catalyst and triethylamine to form crude compound of Formula II.
- the solvents can be removed via distillation and the compound of Formula II is precipitated from the remaining reaction mixture through a series of pH adjustment steps and isolated by filtration or centrifugation.
- the crude compound of Formula II prepared by this process contains a lot of impurities, the said impurities not resulting from the above reaction but in fact resulting from impurities in the starting material, from the compound of Formula I. Due to the impurities in the starting material, the resulting compound of Formula II does not meet the relevant standards.
- the impurities for example, nitro and dinitro impurities present in the final product for any reason are undesirable.
- the regulatory agencies require the content of impurities to the minimum possible extent to ensure maximum safety and avoid toxicity including genotoxicity because of such impurities.
- the content of an individual impurity in the final product should not exceed a certain limit.
- the process impurities should be maintained below set limits.
- the specific limit may be achieved by using pure raw materials, controlling process parameters, such as temperature, pressure, time and stoichiometric ratio, and purification steps, such as crystallization, distillation, and liquid-liquid extraction, in the manufacturing process.
- the purity of the chemical compounds can be measured by chromatographic techniques such as high pressure liquid chromatography (HPLC) or by gas chromatography (GC).
- US5424481 discloses the preparation of the compound of Formula I involving the reaction of p- toluenesulfonyl chloride with chloroacetic acid in the presence of sodium sulfite and sodium bicarbonate to obtain 4-methylsulfonyltoluene, which is further converted to 4-methylsulfonyl-2- nitrotoluene (hereinafter referred to as the compound of Formula V) by nitration reaction.
- the compound of Formula V is further converted to the compound of Formula I by oxidation reaction using sulfuric acid and vanadium pentoxide as a catalyst.
- the yield of the compound Formula I obtained by using this method is only 81%.
- Bioorganic & Medicinal Chemistry 10 (2002) 1841-1854 discloses the preparation of the compound of Formula IV involving the reaction of the compound of formula III with chlorosulfonic acid at 0-5°C using chloroform as a solvent to obtain the compound of Formula IV with yield of only 83.54%.
- the said journal reference does not disclose the further conversion of the compound of Formula IV to the compound of Formula I.
- US7285678 discloses a purification method of the compound of Formula I which involves the dissolution of the compound of Formula I by adjusting the pH 2-10, followed by contacting an aqueous solution of the compound of Formula I with activated carbon, treating an aqueous solution of the compound of Formula I with sufficient base to hydrolyze undesired nitro and dinitro substituted impurities; followed by maintaining the resulting aqueous solution comprising the compound of Formula I at a temperature of up to about 95°C, and adjusting the pH of said solution to about a pH which is sufficient to affect crystallization of the compound of Formula I upon cooling.
- CN106699616 discloses a process for purification of the compound of Formula I by dissolving the compound of Formula I in an appropriate amount of solvent and the resulting reaction mixture is heated to 30-150°C under stirring for 0-2 h. The compound of Formula I is precipitated by the addition or without addition of solvent.
- the CN’616 discloses a lengthy list of the solvents such as alcohol solvents selected from methanol, ethanol, propanol, butanol, pentanol, hexanol, cyclohexanol, ethylene glycol, propylene glycol, 2-methoxyethanol, 2-ethoxyethanol, benzyl alcohol, ether solvents selected from diethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2- dimethoxyethane, dioxane, anisole; alkane solvents selected from petroleum ether, pentane, n- hexane, cyclohexane, octane, heptane, 1,2,3,4-tetralin, chlorine-containing solvents selected from methyl chloride, dichloromethane, chloroform, carbon tetrachloride, 1 ,2-dichloroethane, 1,1-
- CN’616 specifically demonstrates the purification of the compound of Formula I by using solvents such as methanol, ethanol, dichloromethane and toluene. CN’616 fails to provide the compound of Formula I with an acceptable level of impurities.
- the inventors of the present invention provide the process for the preparation of the compound of the Formula I with improved yield and purity.
- An object of the present invention is to provide a process for the preparation of the compound of Formula I with improved purity.
- Another object of the present invention is to provide a novel intermediate of a compound of Formula IVc which can be used for the synthesis of the compound of Formula I.
- the present invention relates to a novel, efficient and industrially advantageous process for the preparation of the compound of Formula I.
- a first aspect of the present invention is to provide a process for the preparation of the compound of Formula I comprising reacting the compound of Formula III with chlorosulfonic acid in the presence of a reagent selected from thionyl chloride, phosgene or oxalyl chloride and ethylene dichloride as a solvent to obtain a compound Formula IV.
- a reagent selected from thionyl chloride, phosgene or oxalyl chloride and ethylene dichloride as a solvent to obtain a compound Formula IV.
- the compound of Formula IV is reacted with alkali metal sulfite and carboxylic acid or salts thereof in the presence of inorganic base to obtain the compound of Formula IVc.
- the compound of Formula IVc is converted to a compound of Formula V, which is then oxidized by using a catalyst to obtain the crude compound of Formula I.
- the crude compound of Formula I obtained is purified.
- a second aspect of the present invention is to provide a novel intermediate of the compound of Formula IVc which can be further converted into the compound of Formula I wherein A is H or Na or K.
- a third aspect of the present invention is to provide a process for the purification of the compound of Formula I using ether as a solvent.
- the process for the purification of compound of Formula I is depicted in scheme-II herein below
- the present invention discloses a process for the preparation of a compound of Formula I with improved purity.
- the starting material of the process can be prepared as per process disclosed in US4804792.
- a process for the preparation of the compound of formula I as depicted in Scheme-I.
- step (a) a compound of Formula III is reacted with chlorosulfonic acid in the presence of a reagent selected from thionyl chloride, phosgene or oxalyl chloride and using ethylene dichloride as a solvent to obtain a compound Formula IV.
- a reagent selected from thionyl chloride, phosgene or oxalyl chloride and using ethylene dichloride as a solvent to obtain a compound Formula IV.
- step (a) wherein volume of the ethylene dichloride solvent with respect to weight of the compound of Formula III ranges from 2 to 10.
- step (a) wherein the molar ratio of the compound of Formula IP to chlorosulfonic acid ranges from 1:1 to 1:8.
- step (a) wherein the molar ratio of the compound of Formula III to thionyl chloride, phosgene or oxalyl chloride ranges from 1:0.5 to 1:5.
- step (a) The process of the step (a) is carried out at a temperature ranging between 25°C and 90°C.
- step (b) the compound of Formula IV obtained in step (a) is reacted with alkali metal sulfite and carboxylic acid or salts thereof in the presence of inorganic base to obtain a compound of Formula IVc followed by conversion to a compound of Formula V.
- A is H or Na or K.
- step (b) is carried out at a temperature of 0°C -105°C.
- step (b) wherein the alkali metal sulfite includes sodium sulfite, potassium sulfite and the combination thereof.
- step (b) wherein the molar ratio of the compound of Formula IV to alkali metal sulfite ranges from 1:1 to 1:3.
- step (b) wherein inorganic base is selected from sodium hydroxide, sodium carbonate, sodium bicarbonate, potassium hydroxide, potassium carbonate, potassium bicarbonate and combinations thereof.
- step (b) wherein the molar ratio of the compound of Formula IV to inorganic base ranges from 1:1 to 1:10.
- step (b) wherein carboxylic acid is selected from chloroacetic acid, trichloroacetic acid, acetic acid and alkali metal salts thereof, preferably sodium and potassium salt.
- step (b) wherein the molar ratio of the compound of Formula IV to the carboxylic acid or alkali metal salt of the carboxylic acid ranges from 1:1 to 1:5.
- the compound of Formula IVc can be isolated.
- the compound of Formula IVc can be converted in-situ to the compound of Formula V.
- the compound of Formula IVc is converted to the compound of Formula V by heating at 70°C- 100°C.
- step (c) wherein the oxidation is carried out using nitric acid as an oxidising agent and sulphuric acid as a reaction media in the presence of a catalyst.
- step (c) wherein nitric acid is used from 30% to 70% strength by weight.
- step (c) the molar ratio of the compound of Formula V to nitric acid ranges from 1:1 to 1:15.
- step (c) wherein sulphuric acid used is from 50% to 98% strength by weight.
- step (c) wherein the molar ratio of the compound of Formula V to sulphuric acid ranges from 1:1 to 1:6.
- step (c) wherein the catalyst used is vanadium catalyst preferably vanadium pentoxide (V2O5) or ammonium metavanadate (NH4VO3).
- step (c) wherein the weight of the catalyst with respect to the weight of the compound of Formula V ranges from 0.5% to 25%.
- step (d) the compound of Formula I as obtained in step (c) is purified using ether.
- step (d) wherein volume of the ether solvent with respect to weight of the compound of Formula I ranges from 1 to 10.
- step (d) wherein the ether solvent is selected from group consisting of dimethyl ether, ethyl methyl ether, diethyl ether, 1,4-dioxane, diglyme, ethylene glycol, tetrahydrofuran, methyl-/c/7-butyl ether, 1 ,2-dim ethoxy ethane, anisole and combinations thereof.
- the process of step (d) wherein the purification of the compound of Formula I is carried out at a temperature ranging from 30°C to 110°C by employing a technique selected from crystallization, recrystallization and filtration.
- the compound of Formula I can be purified by using ether or combinations thereof as described above.
- An embodiment of the invention relates to a process for purification of the compound of Formula I on treating with ether or combinations thereof results in pure compound of Formula I having acceptable or negligible impurities.
- Step-b Synthesis of the compound of Formula IVc and Formula V (2-nitro-4-methylsulfonyl toluene)
- the compound of Formula IVc (wherein A is Na) is identified by using 1H NMR.
- 1,4-dioxane and crude compound of Formula I (100g) was charged at 25°C and the mixture was heated to 50°C-100°C, stirred and filtered to obtain a filtrate. The filtrate was cooled and stirred to precipitate solids. The precipitated solids were filtered and washed by 1,4-dioxane. The wet cake was dried to obtain the compound of Formula I. (purity > 99%).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to a process for the preparation of 2-nitro-4-methylsulfonyl benzoic acid of formula I. The present invention also relates to a process for the purification of 2-nitro-4-methylsulfonyl benzoic acid of formula I.
Description
A PROCESS FOR THE PREPARATION OF PURE 2-NITRO-4-METHYLSULFONYL
BENZOIC ACID
FIELD OF THE INVENTION:
The present invention relates to a novel process for the preparation of a key intermediate, 2-nitro- 4-methylsulfonyl benzoic acid.
The present invention also relates to a process for the preparation of pure 2-nitro-4-methylsulfonyl benzoic acid.
BACKGROUND
2-nitro-4-methylsulfonyl benzoic acid (Formula I) is a key intermediate for the synthesis of a herbicide, Mesotrione.
Formula I
Mesotrione is used as a selective herbicide, especially in maize and is sold under brand names such as Callisto and Tenacity. It was first marketed by Syngenta in 2001. Mesotrione is hereinafter referred to as the following compound of Formula II.
Formula II.
Several synthetic methods have been reported in the literature to prepare the compound of Formula
Generally, the compound of Formula II can be manufactured by reacting the compound of Formula I with phosgene in the presence of an organic solvent to provide the corresponding acid chloride, the acid chloride intermediate can then be reacted with 1,3-cyclohexanedione in the presence of a cyanide catalyst and triethylamine to form crude compound of Formula II. The solvents can be removed via distillation and the compound of Formula II is precipitated from the remaining reaction mixture through a series of pH adjustment steps and isolated by filtration or centrifugation. The crude compound of Formula II prepared by this process contains a lot of impurities, the said impurities not resulting from the above reaction but in fact resulting from impurities in the starting material, from the compound of Formula I. Due to the impurities in the starting material, the resulting compound of Formula II does not meet the relevant standards.
The impurities, for example, nitro and dinitro impurities present in the final product for any reason are undesirable. The regulatory agencies require the content of impurities to the minimum possible extent to ensure maximum safety and avoid toxicity including genotoxicity because of such impurities.
It is usually required that the content of an individual impurity in the final product should not exceed a certain limit. As per regulatory guidance for manufacturers the process impurities should be maintained below set limits. The specific limit may be achieved by using pure raw materials, controlling process parameters, such as temperature, pressure, time and stoichiometric ratio, and purification steps, such as crystallization, distillation, and liquid-liquid extraction, in the manufacturing process.
It is always advantageous to use an intermediate of high purity which is free from the undesired impurities or such impurities should be present in acceptable amounts. The purity of the chemical compounds can be measured by chromatographic techniques such as high pressure liquid chromatography (HPLC) or by gas chromatography (GC).
In order to overcome the above problems, it is necessary to develop a process for the preparation of a pure key intermediate compound of Formula I for the synthesis of the compound of Formula II.
There are several methods disclosed in the prior art for preparation of the compound of Formula I.
US5424481 discloses the preparation of the compound of Formula I involving the reaction of p- toluenesulfonyl chloride with chloroacetic acid in the presence of sodium sulfite and sodium bicarbonate to obtain 4-methylsulfonyltoluene, which is further converted to 4-methylsulfonyl-2- nitrotoluene (hereinafter referred to as the compound of Formula V) by nitration reaction. The compound of Formula V is further converted to the compound of Formula I by oxidation reaction using sulfuric acid and vanadium pentoxide as a catalyst. However, the yield of the compound Formula I obtained by using this method is only 81%.
Bioorganic & Medicinal Chemistry 10 (2002) 1841-1854 discloses the preparation of the compound of Formula IV involving the reaction of the compound of formula III with chlorosulfonic acid at 0-5°C using chloroform as a solvent to obtain the compound of Formula IV with yield of only 83.54%. The said journal reference does not disclose the further conversion of the compound of Formula IV to the compound of Formula I.
However there are limited uses of the chloroform as a solvent on a large scale due to its anesthetic properties and its other health hazards.
US7285678 discloses a purification method of the compound of Formula I which involves the dissolution of the compound of Formula I by adjusting the pH 2-10, followed by contacting an aqueous solution of the compound of Formula I with activated carbon, treating an aqueous solution of the compound of Formula I with sufficient base to hydrolyze undesired nitro and dinitro substituted impurities; followed by maintaining the resulting aqueous solution comprising the compound of Formula I at a temperature of up to about 95°C, and adjusting the pH of said solution to about a pH which is sufficient to affect crystallization of the compound of Formula I upon cooling.
Thus, the process disclosed in the US’678 is economically not viable as it involves the use of high temperature and involves the use of acid-base purification which makes the process more tedious.
CN106699616 discloses a process for purification of the compound of Formula I by dissolving the compound of Formula I in an appropriate amount of solvent and the resulting reaction mixture is heated to 30-150°C under stirring for 0-2 h. The compound of Formula I is precipitated by the addition or without addition of solvent.
However, the CN’616 discloses a lengthy list of the solvents such as alcohol solvents selected from methanol, ethanol, propanol, butanol, pentanol, hexanol, cyclohexanol, ethylene glycol, propylene glycol, 2-methoxyethanol, 2-ethoxyethanol, benzyl alcohol, ether solvents selected from diethyl ether, ethylene glycol dimethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2- dimethoxyethane, dioxane, anisole; alkane solvents selected from petroleum ether, pentane, n- hexane, cyclohexane, octane, heptane, 1,2,3,4-tetralin, chlorine-containing solvents selected from methyl chloride, dichloromethane, chloroform, carbon tetrachloride, 1 ,2-dichloroethane, 1,1- dichloroethane, and chlorobenzene, benzene ring- containing solvent selected from group consisting of benzene, toluene, phenol, and methylphenol, acetonitrile, pyrrolidone.
Further CN’616 specifically demonstrates the purification of the compound of Formula I by using solvents such as methanol, ethanol, dichloromethane and toluene. CN’616 fails to provide the compound of Formula I with an acceptable level of impurities.
There is a continuous need to develop a simple, economically advantageous and industrially viable process for preparation of the pure compound of Formula I having acceptable levels of impurities.
The inventors of the present invention provide the process for the preparation of the compound of the Formula I with improved yield and purity.
OBJECTS OF THE INVENTION
The objects of the present invention are described herein below:
An object of the present invention is to provide a process for the preparation of the compound of Formula I with improved purity.
Another object of the present invention is to provide a novel intermediate of a compound of Formula IVc which can be used for the synthesis of the compound of Formula I.
Yet another object of the present invention is to provide a process for the preparation of the pure compound of Formula I which employs industrially feasible solvent suitable for large scale batch production.
Further object of the present invention is to provide the process for the preparation of the compound of Formula I with acceptable levels of impurities.
Other objects and advantages of the present invention will be more apparent from the following description which is not intended to limit the scope of the present invention. SUMMARY OF THE INVENTION
The present invention relates to a novel, efficient and industrially advantageous process for the preparation of the compound of Formula I.
A first aspect of the present invention is to provide a process for the preparation of the compound of Formula I comprising reacting the compound of Formula III with chlorosulfonic acid in the presence of a reagent selected from thionyl chloride, phosgene or oxalyl chloride and ethylene dichloride as a solvent to obtain a compound Formula IV. The compound of Formula IV is reacted with alkali metal sulfite and carboxylic acid or salts thereof in the presence of inorganic base to obtain the compound of Formula IVc. The compound of Formula IVc is converted to a compound of Formula V, which is then oxidized by using a catalyst to obtain the crude compound of Formula I.
The crude compound of Formula I obtained is purified.
The process for preparation of pure compound of Formula I is depicted in scheme-I herein below:
Scheme-I
A second aspect of the present invention is to provide a novel intermediate of the compound of Formula IVc which can be further converted into the compound of Formula I
wherein A is H or Na or K.
A third aspect of the present invention is to provide a process for the purification of the compound of Formula I using ether as a solvent.
The process for the purification of compound of Formula I is depicted in scheme-II herein below
Scheme-II DETAILED DESCRIPTION OF THE INVENTION
The present invention discloses a process for the preparation of a compound of Formula I with improved purity.
The starting material of the process, the compound of Formula III, can be prepared as per process disclosed in US4804792. In accordance with the first aspect of the present invention there is provided a process for the preparation of the compound of formula I as depicted in Scheme-I.
Scheme-I
The process is described herein after:
In step (a) a compound of Formula III is reacted with chlorosulfonic acid in the presence of a reagent selected from thionyl chloride, phosgene or oxalyl chloride and using ethylene dichloride as a solvent to obtain a compound Formula IV.
The process of the step (a) wherein volume of the ethylene dichloride solvent with respect to weight of the compound of Formula III ranges from 2 to 10.
The process of the step (a) wherein the molar ratio of the compound of Formula IP to chlorosulfonic acid ranges from 1:1 to 1:8.
The process of the step (a) wherein the molar ratio of the compound of Formula III to thionyl chloride, phosgene or oxalyl chloride ranges from 1:0.5 to 1:5.
The process of the step (a) is carried out at a temperature ranging between 25°C and 90°C.
In step (b) the compound of Formula IV obtained in step (a) is reacted with alkali metal sulfite and carboxylic acid or salts thereof in the presence of inorganic base to obtain a compound of Formula IVc followed by conversion to a compound of Formula V.
wherein A is H or Na or K.
The process of step (b) is carried out at a temperature of 0°C -105°C.
The process of the step (b), wherein the alkali metal sulfite includes sodium sulfite, potassium sulfite and the combination thereof. The process of step (b) wherein the molar ratio of the compound of Formula IV to alkali metal sulfite ranges from 1:1 to 1:3.
The process of step (b) wherein inorganic base is selected from sodium hydroxide, sodium carbonate, sodium bicarbonate, potassium hydroxide, potassium carbonate, potassium bicarbonate and combinations thereof. The process of step (b) wherein the molar ratio of the compound of Formula IV to inorganic base ranges from 1:1 to 1:10.
The process of step (b) wherein carboxylic acid is selected from chloroacetic acid, trichloroacetic acid, acetic acid and alkali metal salts thereof, preferably sodium and potassium salt.
The process of step (b) wherein the molar ratio of the compound of Formula IV to the carboxylic acid or alkali metal salt of the carboxylic acid ranges from 1:1 to 1:5.
In one embodiment the compound of Formula IVc can be isolated.
In another embodiment the compound of Formula IVc can be converted in-situ to the compound of Formula V.
The compound of Formula IVc is converted to the compound of Formula V by heating at 70°C- 100°C.
The process of step (c) wherein the oxidation is carried out using nitric acid as an oxidising agent and sulphuric acid as a reaction media in the presence of a catalyst.
The process of step (c) wherein nitric acid is used from 30% to 70% strength by weight.
The process of step (c) the molar ratio of the compound of Formula V to nitric acid ranges from 1:1 to 1:15.
The process of step (c) wherein sulphuric acid used is from 50% to 98% strength by weight.
The process of step (c) wherein the molar ratio of the compound of Formula V to sulphuric acid ranges from 1:1 to 1:6.
The process of step (c) wherein the catalyst used is vanadium catalyst preferably vanadium pentoxide (V2O5) or ammonium metavanadate (NH4VO3).
The process of step (c) wherein the weight of the catalyst with respect to the weight of the compound of Formula V ranges from 0.5% to 25%.
In step (d) the compound of Formula I as obtained in step (c) is purified using ether.
The process of step (d) wherein volume of the ether solvent with respect to weight of the compound of Formula I ranges from 1 to 10.
The process of step (d) wherein the ether solvent is selected from group consisting of dimethyl ether, ethyl methyl ether, diethyl ether, 1,4-dioxane, diglyme, ethylene glycol, tetrahydrofuran, methyl-/c/7-butyl ether, 1 ,2-dim ethoxy ethane, anisole and combinations thereof.
The process of step (d) wherein the purification of the compound of Formula I is carried out at a temperature ranging from 30°C to 110°C by employing a technique selected from crystallization, recrystallization and filtration.
In accordance with the second aspect of the present invention there is provided an intermediate of the compound of Formula IVc.
wherein A is H or Na or K.
In accordance with the third aspect of the present invention there is provided a process for the purification of the compound of formula I. The purification is as described in step (d) of the first aspect.
The compound of Formula I can be purified by using ether or combinations thereof as described above.
An embodiment of the invention relates to a process for purification of the compound of Formula I on treating with ether or combinations thereof results in pure compound of Formula I having acceptable or negligible impurities.
The inventors of the present invention have observed that the process for the purification of the compound of Formula I when carried out by using ether as solvent, provides the compound of Formula I with improved purity and acceptable levels of impurities. The said compound of Formula I can be used for the synthesis of the compound of Formula II.
EXAMPLES:
Example 1:
Step-a: Synthesis of the compound of Formula IV (3-nitro-4-methylbenzenesulfonyl chloride)
In a 2L four-necked flask, chlorosulfonic acid (340 g), ethylene dichloride (1L) and o-nitrotoluene (200 g) were added and the reaction mixture was heated to 80°C-85°C. The reaction mixture was stirred for ~3 hours and cooled to 60°C-65°C. To the reaction mixture, thionyl chloride (191 g) was added and the reaction mixture was stirred. After completion of the reaction, the reaction mass was cooled to 25°C-30°C and poured into chilled water (200 ml). The organic layers were separated and washed with water (100 ml). The organic layer was further concentrated to obtain the compound of Formula IV. (Purity: 95%, Yield: 99%).
Step-b: Synthesis of the compound of Formula IVc and Formula V (2-nitro-4-methylsulfonyl toluene)
In a 3L four-necked flask, sodium sulfite (184 g), sodium bicarbonate (478 g) and water (1.72L) were charged and the reaction mixture was cooled to 0°C-5°C. To the reaction mixture, the compound of Formula IV (as obtained in step-1) was added at 0°C-30°C and stirred for 1-3 h. A solution of chloroacetic acid (262 g) in water (262 ml) was added at 40°C-45°C and the reaction temperature was raised to 65°C and stirred. The compound of Formula IVc (wherein A is Na) was formed.
The compound of Formula IVc (wherein A is Na) is identified by using 1H NMR.
1H NMR :(300 MHz, DMSO): 8.444-8.439 (d, 1H); 8.006-7.979 (dd, 1H); 7.450-7.423 (dd, 1H); 4.080 (s, 2H); 2.592 (s, 3H)
The reaction mass heated to 70°C-100°C. After completion of the reaction, the reaction mixture was cooled to 20°C-35°C to precipitate solids. The precipitated solids were filtered and washed with water (500 ml) to obtain wet material. To the wet material, methanol (800 ml) was charged, refluxed to 60°C-65°C and cooled to 0°C-5°C to precipitate solids. The precipitated solids were filtered and dried to obtain the compound of Formula V (Purity: 99.0% , Yield: 80%).
Step-c: Synthesis of the compound of Formula I (2-nitro-4-methylsulfonyl benzoic acid (Crude))
In a 1L flask fitted with a stirrer, 70% sulfuric acid (300 g), the compound of Formula V (100 g) and V2O5 (8 g) were charged and temperature of the reaction mixture was increased to 130°C- 140°C. To the reaction mixture 55% nitric acid (620 ml) was added in 12-20 hours. The reaction mixture was stirred for ~3hrs. After completion of the reaction, water (300 ml) was charged to the reaction mass to precipitate solids. The precipitated solids were filtered and washed with 2% sulphuric acid (100 ml) followed by water (100 ml). The filtered solids were dried to give the compound of Formula I. ( Purity: > 92% , Yield: 92%).
Step-d: Purification of the compound of Formula I
In a 1L flask fitted with a stirrer, 1,4-dioxane and crude compound of Formula I (100g) was charged at 25°C and the mixture was heated to 50°C-100°C, stirred and filtered to obtain a filtrate. The filtrate was cooled and stirred to precipitate solids. The precipitated solids were filtered and washed by 1,4-dioxane. The wet cake was dried to obtain the compound of Formula I. (purity > 99%).
Example 2:
Step-d: Purification of the compound of Formula I
In a 1L flask fitted with a stirrer, tetrahydrofuran and crude compound of Formula I (100g) was charged at 25°C and the mixture was heated to 50-65°C, stirred and filtered to obtain a filtrate. The filtrate was cooled and stirred to precipitate solids. The precipitated solids were filtered and washed by tetrahydrofuran. The wet cake was dried to obtain the compound of Formula I. (purity > 99%).
Example 3:
In a 1L flask fitted with a stirrer, MTBE and crude compound of Formula I (100g) was charged at 25°C and the mixture was heated to 50-65°C, stirred, cooled to RT and washed by MTBE. The wet cake was dried to obtain the compound of Formula I. (purity > 99%).
Example 4:
In a 1L flask fitted with a stirrer, mixture of THF and MTBE and crude compound of Formula I (lOOg) was charged at 25°C and the mixture was heated to 50-65°C, stirred, cooled to RT and washed by MTBE. The wet cake was dried to obtain the compound of Formula I. (purity > 99%).
Example 5:
In a 1L flask fitted with a stirrer, diglyme (200 ml) and crude compound of Formula I (100g) was charged at 25 °C and the mixture was heated to 90-100°C, stirred, cooled to RT and washed by diglyme. The wet cake was dried to obtain the compound of Formula I. (purity > 99%).
The effect of the various organic solvent for purification of the compound of Formula I as disclosed in CN106699616 is depicted in Table No. 1.
Table No. 1:
However, when the purification of the compound of Formula I is carried out using 1,4 dioxane (ether) as a solvent, the impurity level in the compound of I is reduced drastically to acceptable level of impurities which is seen in Table No. 2.
Table No.2:
Conclusion: It has been observed from Table No. 2 that when purification of the compound of Formula I is carried out using 1,4 dioxane as a solvent, the purity of the compound of Formula I increases by at least 4.5%. None of the examples disclosed in CN106699616 provides the purification method which increases the purity of the compound of Formula I by more than 4.0%. Further, when purification of the compound of Formula I is carried out using 1,4 dioxane as a solvent, nitro and dinitro substituted impurity level reduces upto 0%. However, none of the examples disclosed in CN106699616 provides the compound of Formula I with 0% nitro and dinitro substituted impurity.
Also, it has been observed that when purification of the compound of Formula I is carried out using 4 vol of 1,4 dioxane the purity of the compound of Formula I increases by 7.75%.
Thus, when the compound of Formula I is purified by using the process of the present invention used for the synthesis of the compound of Formula II provides the compound of Formula II with desired purity. The inventors of the present invention have also carried out the experiments disclosed in example 1, 2, 3 and 4 of the CN 106699616 and solvent of present invention and provided the comparative data in Table No. 3.
Table No. 3
As per data provided in the Table No. 3, it has been observed that when purification of the compound of Formula I is carried out using 1,4-dioxane as a solvent, the purity increases upto 99.76%. None of the solvent disclosed in the CN106699616 provided the product with purity more than 98%. The other impurities level by using 1,4-dioxane is reduced to 0.16% in comparison to the impurities obtained in the presence of other solvents. Further, when the purification is carried out using ethyl alcohol as a solvent the percentage of total other impurity increases. However, when purification is carried out using 1,4-dioxane as a solvent, there is no increase in other impurity levels.
The embodiments herein and the various features and advantageous details thereof are explained with reference to the non-limiting embodiments in the description. Descriptions of well-known components and processing techniques are omitted so as to not unnecessarily obscure the embodiments herein. The examples used herein are intended merely to facilitate an understanding
of ways in which the embodiments herein may be practiced and to further enable those of skill in the art to practice the embodiments. Accordingly, the examples should not be construed as limiting the scope of the embodiments herein.
The description of the specific embodiments will so fully reveal the general nature of the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that the phraseology or terminology employed herein is for the purpose of description and not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the embodiments as described herein.
While considerable emphasis has been placed herein on the particular features of this invention, it will be appreciated that various modifications can be made, and that many changes can be made in the preferred embodiments without departing from the principles of the invention. These and other modifications in the nature of the invention or the preferred embodiments will be apparent to those skilled in the art from the invention herein, whereby it is to be distinctly understood that the foregoing descriptive matter is to be interpreted merely as illustrative of the invention and not as a limitation.
Claims
1. A process for the preparation of the compound of Formula I;
said process comprising the steps of: a) reacting the compound of Formula III,
with chlorosulfonic acid in the presence of a reagent selected from thionyl chloride, phosgene or oxalyl chloride and ethylene dichloride as a solvent to obtain the compound Formula IV,
b) reacting the compound of Formula IV with alkali metal sulfite and carboxylic acid or salts thereof in the presence of inorganic base to obtain a compound of Formula IVc followed by a conversion to a compound of Formula V,
c) oxidizing the compound of Formula V in the presence of a catalyst to obtain the crude compound of Formula I, and
1 d) purifying the compound of Formula I obtained in the step (c) with ether.
2. A process for purification of the compound of Formula I comprising; treating the crude compound of Formula I with ether or combinations thereof to obtain the pure compound of Formula I
3. The process as claimed in the claim 1, wherein volume of the ethylene di chloride solvent with respect to weight of the compound of Formula III ranges from 2 to 10.
4. The process as claimed in the claim 1 , wherein the molar ratio of the compound of Formula III to chlorosulfonic acid ranges from 1:1 to 1:8.
5. The process as claimed in the claim 1 , wherein the molar ratio of the compound of Formula
III to thionyl chloride, phosgene or oxalyl chloride ranges from 1:0.5 to 1:5.
6. The process as claimed in the claim 1, wherein the temperature of step (a) ranges from 25°C to 90°C.
7. The process as claimed in the claim 1, wherein i. the inorganic base is selected from a group consisting of sodium hydroxide, sodium carbonate, sodium bicarbonate, potassium hydroxide, potassium carbonate, potassium bicarbonate and combinations thereof, and ii. the molar ratio of the compound of Formula IV to inorganic base ranges from 1:1 to 1:10.
8. The process as claimed in the claim 1, wherein the temperature of step (b) ranges from 0°C to 105°C.
9. The process as claimed in the claim 1, wherein i. the alkali metal sulfite selected from a group consisting of sodium sulfite, potassium sulfite and the combination thereof, and ii. the molar ratio of the compound of Formula IV to alkali metal sulfite ranges from 1:1 to 1:3.
10. The process as claimed in the claim 1, wherein a. the carboxylic acid is selected from a group consisting of chloroacetic acid, trichloroacetic acid or acetic acid, and b. the salt of carboxylic acid is alkali metal salt selected from a group consisting of sodium or potassium salt.
11. The process as claimed in the claim 1, wherein the molar ratio of the compound of Formula
IV to the carboxylic acid or salt thereof ranges from 1:1 to 1:5.
12. The process as claimed in the claim 1, wherein the compound of Formula IVc is isolated and heated at 70°C to 100°C to obtain the compound of Formula V.
13. The process as claimed in the claim 1, wherein the compound of Formula IVc is converted in situ by heating at 70°C to 100°C to obtain the compound of Formula V.
14. The process as claimed in the claim 1, wherein the oxidation of the compound of Formula
V is carried out using nitric acid in the presence of sulphuric acid.
15. The process as claimed in the claim 14, wherein
i. strength of sulphuric acid ranges from 50% to 98% by weight, and ii. the molar ratio of the compound of Formula V to sulphuric acid ranges from 1 : 1 to 1:6.
16. The process as claimed in the claim 14, wherein i. strength of nitric acid ranges from 30% to 70% by weight, and ii. the molar ratio of the compound of Formula V to nitric acid ranges from 1 : 1 to 1:15.
17. The process as claimed in the claim 1, wherein i. catalyst is a vanadium catalyst selected from the group consisting of vanadium pentoxide (V2O5) or ammonium metavanadate (NH4VO3), and ii. the weight of the catalyst with respect to the weight of the compound of Formula V ranges from 0.5% to 25%.
18. The process as claimed in the claim 1 and 2, wherein i. the ether solvent is selected from the group consisting of dimethyl ether, ethyl methyl ether, diethyl ether, 1,4-dioxane, ethylene glycol, tetrahydrofuran, diglyme, methyl-/c/7-butyl ether, 1 ,2-dim ethoxy ethane, anisole and combinations thereof, and ii. wherein the volume of the ether solvent with respect to weight of the compound of Formula V ranges from 1 to 10.
19. The process as claimed in the claim 1 and 2, wherein the purification is carried out at a temperature ranging from 30°C to 110°C.
20. A compound of formula IVc
wherein A is H or Na or K.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202121030817 | 2021-07-09 | ||
PCT/IN2022/050623 WO2023281536A1 (en) | 2021-07-09 | 2022-07-08 | A process for the preparation of pure 2-nitro-4-methylsulfonyl benzoic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4366771A1 true EP4366771A1 (en) | 2024-05-15 |
Family
ID=84800431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22837192.8A Pending EP4366771A1 (en) | 2021-07-09 | 2022-07-08 | A process for the preparation of pure 2-nitro-4-methylsulfonyl benzoic acid |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4366771A1 (en) |
CN (1) | CN117794567A (en) |
WO (1) | WO2023281536A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5136043A (en) * | 1989-06-17 | 1992-08-04 | Hoechst Aktiengesellschaft | Process for the preparation of aromatic sulfonyl chlorides |
DE4235155A1 (en) * | 1992-10-19 | 1994-04-21 | Basf Ag | Process for the preparation of methylsulfonylbenzoic acids |
CN103121961B (en) * | 2013-02-05 | 2014-10-01 | 江苏中旗作物保护股份有限公司 | Synthesis method of weedicide mesotrione intermediate 2-nitro-4-mesyltoluene |
CN106699616A (en) * | 2016-11-17 | 2017-05-24 | 北京颖泰嘉和生物科技股份有限公司 | Purification method of new 2-nitro-4-methylsulfonylbenzoic acid |
-
2022
- 2022-07-08 EP EP22837192.8A patent/EP4366771A1/en active Pending
- 2022-07-08 WO PCT/IN2022/050623 patent/WO2023281536A1/en active Application Filing
- 2022-07-08 CN CN202280054627.8A patent/CN117794567A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2023281536A1 (en) | 2023-01-12 |
CN117794567A (en) | 2024-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5642422B2 (en) | Intermediate of isoxazolin-3-ylacylbenzene and process for producing the same | |
JPH0240660B2 (en) | ||
EP0092909B1 (en) | Process for producing aminophenyl-beta-hydroxyethylsulfone | |
US6657085B2 (en) | Process for the preparation of aniline compounds | |
US10377703B2 (en) | Method for producing 4-(trifluoromethylsulfonyl)phenol compound | |
WO2023281536A1 (en) | A process for the preparation of pure 2-nitro-4-methylsulfonyl benzoic acid | |
US6342630B1 (en) | Chemical process | |
JP4161290B2 (en) | Process for producing pyrimidinyl alcohol derivatives and synthetic intermediates thereof | |
US7745471B2 (en) | Derivatives of 1,2-benzisoxazole-3-methane sulfonic acid as novel intermediates for the synthesis of zonisamide | |
JPS60152449A (en) | 3-amino-4-fluorophenyl ether and its preparation | |
US7923571B2 (en) | Process for preparing substituted 2-alkoxycarbonyl-3-aminothiophenes | |
EP1070038B1 (en) | New processes for the preparation of 3-bromoanisole and 3-bromonitrobenzene | |
JP6915189B1 (en) | High-purity 2-naphthylacetonitrile and its production method | |
US20090036711A1 (en) | Process for Producing O-Methyl-N-Nitroisourea | |
EP3456705A1 (en) | Method for producing nitrobenzene compound | |
PL129167B1 (en) | Process for preparing esters of 3-acylazopropionic acid | |
JPH051023A (en) | Production of alkanesulfonanilide derivative | |
JP2024058272A (en) | Method for producing 1-alkyl-5-hydroxypyrazole | |
KR100730766B1 (en) | New method for preparing biphenylacetic acid | |
CN115057768A (en) | Synthetic method of 3, 5-dichloro-4-methoxybenzoic acid | |
JPS63303958A (en) | Production of 2-amino-4,6-dichloro-5-alkylphenol | |
JP2002322172A (en) | PRODUCTION METHOD FOR o-SULFOBENZOIC ACID ANHYDRIDE | |
MXPA00011047A (en) | Method for producing isoxazoline-3-yl-acyl benzene | |
JPH0761953A (en) | 4,6-dichloro-2-nitroresorcin | |
KR20010073582A (en) | Method of preparing an aromatic propionic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20240105 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |